Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs

BACKGROUND: Monotherapy with ritonavir-boosted PIs (PI/r) has been used to simplify treatment of HIV-1-infected patients. In previous studies raltegravir intensification evidenced ongoing viral replication and reduced T cell activation, preferentially in subjects receiving PI-based triple ART. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Puertas, Maria C, Gómez-Mora, Elisabet, Santos, José R, Moltó, José, Urrea, Víctor, Morón-López, Sara, Hernández-Rodríguez, Agueda, Marfil, Silvia, Martínez-Bonet, Marta, Matas, Lurdes, Muñoz-Fernández, Mª Angeles, Clotet, Bonaventura, Blanco, Julià, Martinez-Picado, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005067/
https://www.ncbi.nlm.nih.gov/pubmed/29635527
http://dx.doi.org/10.1093/jac/dky106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005067/
https://www.ncbi.nlm.nih.gov/pubmed/29635527
http://dx.doi.org/10.1093/jac/dky106

Ejemplares similares